Management of Atypical Cells of Undetermined Significance (ASC-US) in Pap Tests

Initial Management Algorithm for ASC-US

The Centers for Disease Control and Prevention recommends that for patients with ASC-US on Pap smear, follow-up with repeat Pap tests every 4-6 months for 2 years until three consecutive smears are negative is the recommended management approach 1, 2, 3, 4
For patients with ASC-US Pap smear results, management options depend on whether the interpretation is qualified by a statement indicating a suspected neoplastic process 1, 2, 5
Follow-up with Pap tests without immediate colposcopy is acceptable when the diagnosis of ASC-US is not qualified further 1, 2
Repeat Pap tests should be performed every 4-6 months for 2 years until three consecutive smears have been negative 1, 2, 4

If a second report of ASC-US occurs during the 2-year follow-up period, the patient should be considered for colposcopic evaluation 1, 2, 4
Women with unqualified ASC-US associated with severe inflammation should be evaluated for an infectious process 1, 2, 4
If specific infections are identified, reevaluation should be performed after appropriate treatment, preferably after 2-3 months 1, 2, 5
If the diagnosis of ASC-US is qualified by a statement indicating a neoplastic process is suspected, manage as if a low-grade squamous intraepithelial lesion (LSIL) is present 1, 2, 4
For high-risk patients, colposcopy should be considered 1, 2, 5

HPV DNA testing can be used as a triage method for women with ASC-US 6
Women who test positive for high-risk HPV types should be referred for colposcopy 6
Women who test negative for high-risk HPV types have a very low risk of high-grade cervical disease and can be followed with routine screening 6

For patients with LSIL, follow-up with Pap tests every 4-6 months is an option, but patients must be carefully selected and considered reliable for follow-up 1, 2, 4
If repeat smears show persistent abnormalities, colposcopy and directed biopsy are indicated 1, 2, 5
Women with high-grade squamous intraepithelial lesions (HSIL) or squamous cell carcinoma should undergo immediate colposcopy and directed biopsy 1, 2, 4

Avoid unnecessary colposcopy for ASC-US with negative high-risk HPV, as this can lead to overtreatment 6
Don't confuse management protocols for ASC-US/HPV-positive (but negative for high-risk types) with those for ASC-US/high-risk HPV-positive 6